Pa ystyriaeth y mae'r Ysgrifennydd Cabinet wedi'i rhoi i'r argymhellion yn adroddiad blynyddol GICOLD 2025 ar Strategaeth Fyd-eang ar gyfer Diagnosio, Rheoli, ac Atal COPD y dylid defnyddio profion sgrinio canser yr ysgyfaint i gynnal sbirometreg ymhlith pobl sydd mewn risg uchel o gael clefyd rhwystrol cronig yr ysgyfaint yn ystod rhaglenni sgrinio canser yr ysgyfaint?
The Welsh Government follows the independent, expert advice of the UK National Screening Committee which does not currently recommend screening for COPD.
The Welsh Government expects health boards to deliver spirometry and fractional exhaled nitric oxide (FeNO) testing in line with clinical standards and National Institute for Health and Care Excellence guidelines. We have emphasised the importance of community-based access to spirometry in the Quality Statement for Respiratory Disease. The NHS Executive is developing new service pathways for new presentations of breathlessness, which are likely to support better community-based provision of spirometry and FeNO.